Showing results (71-80 of 252) with videos related to

Sort By:
Pageof 26
Scientific Reports|November 29, 2025
A systematic review and pharmacovigilance analysis of the risk of agranulocytosis associated with metamizole useAlessia Zinzi, Mario Gaio, Donatella Ruggiero, et al.
Frontiers in Pharmacology|May 23, 2019
Preventable Cases of Oral Anticoagulant-Induced Bleeding: Data From the Spontaneous Reporting SystemAnnamaria Mascolo, Rosanna Ruggiero, Maurizio Sessa, et al.
Respiratory Research|November 14, 2023
The impact of SARS-CoV-2 infection in patients with cystic fibrosis undergoing CFTR channel modulators treatment: a literature reviewAntonio Vitiello, Michela Sabbatucci, Andrea Silenzi, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 26, 2026
Safety profile of fentanyl with different routes of administration: a disproportionality analysis using the EudraVigilance databaseRaffaella Di Napoli, Annamaria Mascolo, Nunzia Balzano, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 10, 2010
Oxygen/ozone protects the heart from acute myocardial infarction through local increase of eNOS activity and endothelial progenitor cells recruitmentClara Di Filippo, Margherita Luongo, Raffaele Marfella, et al.
Drug Safety|March 23, 2025
Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety DatabaseRaffaella Di Napoli, Christophe Richez, Cristina Scavone, et al.
BMJ Open|February 18, 2015
A nomogram to estimate the HbA1c response to different DPP-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of 98 trials with 24 163 patientsKatherine Esposito, Paolo Chiodini, Maria Ida Maiorino, et al.
Clinical and Experimental Medicine|February 23, 2026
Safety profile of FLT3 inhibitors in acute myeloid leukemia: a systematic review and meta-analysis of adverse eventsMario Gaio, Alessia Zinzi, Valerio Liguori, et al.
Frontiers in Neurology|August 27, 2021
Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case ReportGiorgia T Maniscalco, Valentino Manzo, Maria E Di Battista, et al.
Diabetes, Obesity & Metabolism|January 18, 2024
Two years with GIOIA 'Effects of gliflozins and gliptins on markers of cardiovascular damage in type 2 diabetes': A prospective, multicentre, quasi-experimental study on sodium-glucose cotransporter 2 and dipeptidyl peptidase-4 inhibitors in diabetes clinical practiceMiriam Longo, Paola Caruso, Lorenzo Scappaticcio, et al.
Pageof 26